This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Madden, K. P. Search for Related Content PubMed PubMed Citation Articles by Madden, K. P.

Stroke, Vol 25, 2271-2274, Copyright © 1994 by American Heart Association

ARTICLES

Effect of gamma-aminobutyric acid modulation on neuronal ischemia in rabbits

KP Madden
Department of Neurology, Marshfield Clinic (Wis) 54449.

BACKGROUND AND PURPOSE: Antagonists of excitatory neurotransmitters are effective in limiting ischemic damage to the brain and spinal cord, but use in clinical stroke may be limited by side effects. Agonists of inhibitory neurotransmitters, such as gamma-aminobutyric acid (GABA), may provide similar neuroprotection with less severe side effects. This study examines the effect of an agonist and antagonist of the GABA-A receptor on neuronal ischemic damage. METHODS: Either muscimol (a GABA- A agonist) or bicuculline (a GABA-A antagonist) was administered intravenously to groups of rabbits exposed to reversible spinal cord ischemia induced by temporary occlusion of the infrarenal aorta. The duration of occlusion for individual animals was varied, providing a range of ischemia for each experimental group. The group P50 represents the duration (in minutes) associated with 50% probability of resultant permanent paraplegia. Neuroprotection was demonstrated if a drug prolonged the P50 compared with the control group. RESULTS: The P50 of the control group was 26.3 +/- 2.0 minutes. Treatment with intravenous muscimol at 5 mg/kg significantly prolonged the P50 (32.4 +/- 1.3; P = .01). Treatment with intravenous bicuculline at 0.1 mg/kg significantly shortened the P50 (20.6 +/- 1.5; P = .03). The physiological and apparent behavioral effects of the drugs at these doses did not appear substantial. CONCLUSIONS: Pharmacological manipulation of the GABA-A receptor may offer another avenue of therapy for central nervous system ischemia, possibly with less severe associated physiological side effects than other effective drugs.

This article has been cited by other articles:

				M. Oda, S. Kure, T. Sugawara, S. Yamaguchi, K. Kojima, T. Shinka, K. Sato, A. Narisawa, Y. Aoki, Y. Matsubara, et al. Direct Correlation Between Ischemic Injury and Extracellular Glycine Concentration in Mice With Genetically Altered Activities of the Glycine Cleavage Multienzyme System Stroke, July 1, 2007; 38(7): 2157 - 2164. [Abstract] [Full Text] [PDF]

				Z.-L. Ma, X.-P. Gu, Y.-M. Zeng, and Y. Zhang Effect of Sodium Hydroxybutyrate on the Expression of Hippocampal N-Methyl-D-Aspartate Receptor 2B Subunit mRNA in Neonatal Rats with Hypoxic-Ischemic Insult Ann. Clin. Lab. Sci., January 1, 2006; 36(3): 307 - 311. [Abstract] [Full Text] [PDF]

				P. Van Damme, G. Callewaert, J. Eggermont, W. Robberecht, and L. Van Den Bosch Chloride Influx Aggravates Ca2+-Dependent AMPA Receptor-Mediated Motoneuron Death J. Neurosci., June 15, 2003; 23(12): 4942 - 4950. [Abstract] [Full Text] [PDF]

				K. Madden, W. Clark, and N. Lessov Failure of Ischemic Neuroprotection by Potentiators of Gamma-aminobutyric Acid Clin. Med. Res., April 1, 2003; 1(2): 119 - 124. [Abstract] [Full Text] [PDF]

				P. A. Lapchak, D. F. Chapman, S. Y. Nunez, J. A. Zivin, and C. Y. Hsu Dehydroepiandrosterone Sulfate Is Neuroprotective in a Reversible Spinal Cord Ischemia Model : Possible Involvement of GABAA Receptors Editorial Comment: Possible Involvement of GABAA Receptors Stroke, August 1, 2000; 31(8): 1953 - 1957. [Abstract] [Full Text] [PDF]

				P. Lyden, C. Shin, C. Jackson-Friedman, S. Hassid, A. Chong, and R. L. Macdonald Effect of Ganaxolone in a Rodent Model of Cerebral Hematoma Editorial Comment Stroke, January 1, 2000; 31(1): 169 - 175. [Abstract] [Full Text] [PDF]

				P. D. Lyden, C. Jackson-Friedman, L. Lonzo-Doktor, and J. P. Muizelaar Medical Therapy for Intracerebral Hematoma With the {gamma}-Aminobutyric Acid-A Agonist Muscimol Stroke, February 1, 1997; 28(2): 387 - 391. [Abstract] [Full Text]

				Z. B. Yao, X. Li, Z. C. Xu, and J. T. Povlishock GABAergic and Asymmetrical Synapses on Somata of GABAergic Neurons in CA1 and CA3 Regions of Rat Hippocampus: A Quantitative Electron Microscopic Analysis Stroke, August 1, 1996; 27(8): 1411 - 1416. [Abstract] [Full Text]

				M. D. Ginsberg Review : Neuroprotection in Brain Ischemia: An Update (Part II Neuroscientist, May 1, 1995; 1(3): 164 - 175. [Abstract] [PDF]